Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Josephine, Feliciano"'
Autor:
Chen Hu, Charlene Wong, Iftekhar Kalsekar, Qing Huang, Aisha Hasan, Josephine Feliciano, Adam Schoenfeld, Ravi Rajaram, Urmila Chandran, U Hariharan, Tianyi Wang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0b98f6a4dc63419c9fecb0f7f8cdb899
Autor:
Patrick Forde, Julie Brahmer, Vincent Lam, Christine Hann, Melinda Hsu, Josephine Feliciano, Kristen Marrone, Joseph Murray, Paola Ghanem, David Ettinger, Benjamin Levy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/5d0457c652a24c7ba85491195d7cc96e
Autor:
Lei Zheng, Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Cheng Ting Lin, Peter B Illei, Sonye K Danoff, Karthik Suresh, Christine Hann, Aanika Balaji, Melinda Hsu, Josephine Feliciano, Kristen Marrone, Valerie Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Background Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical features, management
Externí odkaz:
https://doaj.org/article/8744b96ba9a44fff9d9e0106c494995a
Autor:
Noushin Niknafs, Archana Balan, Christopher Cherry, Karlijn Hummelink, Kim Monkhorst, Xiaoshan M. Shao, Zineb Belcaid, Kristen A. Marrone, Joseph Murray, Kellie N. Smith, Benjamin Levy, Josephine Feliciano, Christine L. Hann, Vincent Lam, Drew M. Pardoll, Rachel Karchin, Tanguy Y. Seiwert, Julie R. Brahmer, Patrick M. Forde, Victor E. Velculescu, Valsamo Anagnostou
Publikováno v:
Nature Medicine. 29:440-449
Tumor mutation burden is an imperfect proxy of tumor foreignness and has therefore failed to consistently demonstrate clinical utility in predicting responses in the context of immunotherapy. We evaluated mutations in regions of the genome that are u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65c09aa02ded7b6871f42cf4e48e9f1c
https://doi.org/10.1038/s41591-022-02163-w
https://doi.org/10.1038/s41591-022-02163-w
Autor:
Melissa A.L. Vyfhuis, MD PhD, Neha Bhooshan, MD PhD, Whitney M. Burrows, MD, Michelle Turner, NP, Mohan Suntharalingam, MD MBA, James Donahue, MD, Elizabeth M. Nichols, MD, Josephine Feliciano, MD, Søren M. Bentzen, PhD DMSc, Shahed Badiyan, MD, Shamus R. Carr, MD, Joseph Friedberg, MD, Charles B. Simone, II, MD, Martin J. Edelman, MD, Steven J. Feigenberg, MD, Pranshu Mohindra, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 3, Pp 259-269 (2017)
Purpose: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature
Externí odkaz:
https://doaj.org/article/034cf0c96c374203aa5b7ace9eafba67
Autor:
Josephine Feliciano, Michael Lim, Pavan P. Shah, Jarushka Naidoo, Christopher M. Jackson, Kristen A. Marrone, Lawrence Kleinberg, Siddhartha Srivastava, Julie R. Brahmer, John Choi, Patrick M. Forde, Kristin J. Redmond, Jennifer L. Franke, David S. Ettinger, Benjamin Levy, Ravi Medikonda
Publikováno v:
Journal of Neurosurgery. 136:56-66
OBJECTIVE Non–small cell lung cancer (NSCLC) is the most common primary tumor to develop brain metastasis. Prognostic markers are needed to better determine survival after neurosurgical resection of intracranial disease. Given the importance of mut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db133f449a78fd96f3bd049d1c69044d
https://doi.org/10.3171/2020.10.jns201787
https://doi.org/10.3171/2020.10.jns201787
Autor:
Victor E. Velculescu, Julie R. Brahmer, Matthew D. Hellmann, Jamie E. Chaft, Drew M. Pardoll, Rachel Karchin, Robert B. Scharpf, Janis Taube, Jennifer L. Sauter, James M. Isbell, Malcolm V. Brock, Edward Gabrielson, Qing Kay Li, Peter Illei, Franco Verde, Christos Georgiades, Josephine Feliciano, Benjamin Levy, Christine L. Hann, Doreen N. Palsgrove, Lamia Rhymee, Tricia R. Cottrell, Kellie N. Smith, Vilmos Adleff, Alessandro Leal, Jillian Phallen, Samuel Rosner, Daniel C. Bruhm, I.K. Ashok Sivakumar, Kristen Marrone, Jarushka Naidoo, Carolyn Hruban, Noushin Niknafs, James R. White, Patrick M. Forde, Valsamo Anagnostou
Despite the initial successes of immunotherapy, there is an urgent clinical need for molecular assays that identify patients more likely to respond. Here, we report that ultrasensitive measures of circulating tumor DNA (ctDNA) and T-cell expansion ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9635a5d6f44ac7214b2e198664dbe1a1
https://doi.org/10.1158/0008-5472.c.6511197.v1
https://doi.org/10.1158/0008-5472.c.6511197.v1
Autor:
Victor E. Velculescu, Julie R. Brahmer, Matthew D. Hellmann, Jamie E. Chaft, Drew M. Pardoll, Rachel Karchin, Robert B. Scharpf, Janis Taube, Jennifer L. Sauter, James M. Isbell, Malcolm V. Brock, Edward Gabrielson, Qing Kay Li, Peter Illei, Franco Verde, Christos Georgiades, Josephine Feliciano, Benjamin Levy, Christine L. Hann, Doreen N. Palsgrove, Lamia Rhymee, Tricia R. Cottrell, Kellie N. Smith, Vilmos Adleff, Alessandro Leal, Jillian Phallen, Samuel Rosner, Daniel C. Bruhm, I.K. Ashok Sivakumar, Kristen Marrone, Jarushka Naidoo, Carolyn Hruban, Noushin Niknafs, James R. White, Patrick M. Forde, Valsamo Anagnostou
Supplementary Table S1. Summary of patient characteristics Supplementary Table S2. Summary of plasma samples analyzed Supplementary Table S3. Summary of peripheral blood lymphocytes and tumor infiltrating lymphocytes samples analyzed Supplementary Ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124d0b4bc633214944bd209dff0fdd47
https://doi.org/10.1158/0008-5472.22422375
https://doi.org/10.1158/0008-5472.22422375
Autor:
Janis M. Taube, Suzanne L. Topalian, Drew M. Pardoll, Elizabeth M. Jaffee, Hao Wang, Josephine Feliciano, Mark Yarchoan, Mohamad E. Allaf, Elizabeth D. Thompson, Ashley Cimino-Mathews, Robert A. Anders, Patrick M. Forde, Tricia R. Cottrell, Evan J. Lipson, Julie E. Stein
Supplemental Appendix (Figures S1 and S2, Table S1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ed1e4bdcd90cc74ca63e179954003f
https://doi.org/10.1158/1078-0432.22479647
https://doi.org/10.1158/1078-0432.22479647
Autor:
Janis M. Taube, Suzanne L. Topalian, Drew M. Pardoll, Elizabeth M. Jaffee, Hao Wang, Josephine Feliciano, Mark Yarchoan, Mohamad E. Allaf, Elizabeth D. Thompson, Ashley Cimino-Mathews, Robert A. Anders, Patrick M. Forde, Tricia R. Cottrell, Evan J. Lipson, Julie E. Stein
Purpose:Pathologic response assessment of tumor specimens from patients receiving systemic treatment provides an early indication of therapeutic efficacy and predicts long-term survival. Grading systems for pathologic response were first developed fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306dceea7e36d45e003608408c669dff
https://doi.org/10.1158/1078-0432.c.6530270
https://doi.org/10.1158/1078-0432.c.6530270